Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Oncotarget
|
October 17, 2015
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
Huabo Wang, Peter Teriete, Angela Hu, et al.
ACS Chemical Neuroscience
|
June 2, 2017
Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[<sup>11</sup>C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2
Xiaofei Zhang, Katsushi Kumata, Tomoteru Yamasaki, et al.
Molecular Cancer Research : MCR
|
February 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia
Seemana Bhattacharya, Sujan Piya, Huaxian Ma, et al.
Journal of Medicinal Chemistry
|
September 27, 2012
Orally active metabotropic glutamate subtype 2 receptor positive allosteric modulators: structure-activity relationships and assessment in a rat model of nicotine dependence
Shyama Sidique, Raveendra-Panickar Dhanya, Douglas J Sheffler, et al.
The Journal of Biological Chemistry
|
January 19, 2020
A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors
Celeste Romero, Lester J Lambert, Douglas J Sheffler, et al.
Plos One
|
September 13, 2016
Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis
Kate Welsh, Snezana Milutinovic, Robert J Ardecky, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 24, 2005
Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists
Peter C Chua, Johnny Y Nagasawa, Leo S Bleicher, et al.
Journal of Medicinal Chemistry
|
October 14, 2009
Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP)
Russell Dahl, Eduard A Sergienko, Ying Su, et al.
Journal of Medicinal Chemistry
|
November 17, 2020
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer
Huiyu Ren, Nicole A Bakas, Mitchell Vamos, et al.
Molecular Psychiatry
|
April 4, 2025
17β-estradiol status alters NMDAR function and antipsychotic-like activity in female rats
Kimberly M Holter, McKenna G Klausner, Mary Hunter Hite, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Oncotarget
|
October 17, 2015
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
Huabo Wang, Peter Teriete, Angela Hu, et al.
ACS Chemical Neuroscience
|
June 2, 2017
Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[<sup>11</sup>C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2
Xiaofei Zhang, Katsushi Kumata, Tomoteru Yamasaki, et al.
Molecular Cancer Research : MCR
|
February 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia
Seemana Bhattacharya, Sujan Piya, Huaxian Ma, et al.
Journal of Medicinal Chemistry
|
September 27, 2012
Orally active metabotropic glutamate subtype 2 receptor positive allosteric modulators: structure-activity relationships and assessment in a rat model of nicotine dependence
Shyama Sidique, Raveendra-Panickar Dhanya, Douglas J Sheffler, et al.
The Journal of Biological Chemistry
|
January 19, 2020
A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors
Celeste Romero, Lester J Lambert, Douglas J Sheffler, et al.
Plos One
|
September 13, 2016
Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis
Kate Welsh, Snezana Milutinovic, Robert J Ardecky, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 24, 2005
Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists
Peter C Chua, Johnny Y Nagasawa, Leo S Bleicher, et al.
Journal of Medicinal Chemistry
|
October 14, 2009
Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP)
Russell Dahl, Eduard A Sergienko, Ying Su, et al.
Journal of Medicinal Chemistry
|
November 17, 2020
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer
Huiyu Ren, Nicole A Bakas, Mitchell Vamos, et al.
Molecular Psychiatry
|
April 4, 2025
17β-estradiol status alters NMDAR function and antipsychotic-like activity in female rats
Kimberly M Holter, McKenna G Klausner, Mary Hunter Hite, et al.
Page
of 11